A Five Year Plan of Enhanced HCV Monitoring, Primary Care-Based Workforce Development, Rapid Scale‐up of HCV Treatment and Public Health Policy Action in HIV Positive Individuals Within Australia

Trial Profile

A Five Year Plan of Enhanced HCV Monitoring, Primary Care-Based Workforce Development, Rapid Scale‐up of HCV Treatment and Public Health Policy Action in HIV Positive Individuals Within Australia

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Jun 2016

At a glance

  • Drugs Sofosbuvir (Primary) ; Ribavirin
  • Indications Hepatitis C; HIV infections
  • Focus Therapeutic Use
  • Acronyms CEASE
  • Most Recent Events

    • 07 Jun 2016 Study design changed from interventional to observational; Cross- Sectional keyword added.
    • 07 Jun 2016 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.
    • 07 Jun 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Dec 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top